307 related articles for article (PubMed ID: 2918443)
21. Melarsoprol- and pentamidine-resistant Trypanosoma brucei rhodesiense populations and their cross-resistance.
Bernhard SC; Nerima B; Mäser P; Brun R
Int J Parasitol; 2007 Nov; 37(13):1443-8. PubMed ID: 17602691
[TBL] [Abstract][Full Text] [Related]
22. The susceptibility of Trypanosoma congolense and Trypanosoma brucei to isometamidium chloride and its synthetic impurities.
Sahin A; Asencio C; Izotte J; Pillay D; Coustou V; Karembe H; Baltz T
Vet Parasitol; 2014 Jul; 203(3-4):270-5. PubMed ID: 24836423
[TBL] [Abstract][Full Text] [Related]
23. Combined contribution of TbAT1 and TbMRPA to drug resistance in Trypanosoma brucei.
Lüscher A; Nerima B; Mäser P
Mol Biochem Parasitol; 2006 Dec; 150(2):364-6. PubMed ID: 16935360
[No Abstract] [Full Text] [Related]
24. Developmentally regulated sensitivity of Trypanosoma brucei brucei to the cytotoxic effects of human high-density lipoprotein.
Moore DR; Smith A; Hager KM; Waldon R; Esko JD; Hajduk SL
Exp Parasitol; 1995 Sep; 81(2):216-26. PubMed ID: 7556564
[TBL] [Abstract][Full Text] [Related]
25. An in vitro assay for drug sensitivity of Trypanosoma congolense using in vitro-derived metacyclic trypanosomes.
Gray MA; Peregrine AS
Acta Trop; 1993 Sep; 54(3-4):291-300. PubMed ID: 7902666
[TBL] [Abstract][Full Text] [Related]
26. Studies of quinapyramine-resistance of Trypanosoma brucei evansi in China.
Liao D; Shen J
Acta Trop; 2010 Dec; 116(3):173-7. PubMed ID: 20813092
[TBL] [Abstract][Full Text] [Related]
27. Induction of resistance to melarsenoxide cysteamine (Mel Cy) in Trypanosoma brucei brucei.
Pospichal H; Brun R; Kaminsky R; Jenni L
Acta Trop; 1994 Dec; 58(3-4):187-97. PubMed ID: 7709858
[TBL] [Abstract][Full Text] [Related]
28. Comparative efficacy assessment of pentamidine isethionate and diminazene aceturate in the chemotherapy of Trypanosoma brucei brucei infection in dogs.
Akpa PO; Ezeokonkwo RC; Eze CA; Anene BM
Vet Parasitol; 2008 Feb; 151(2-4):139-49. PubMed ID: 18155842
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of a short-term in vitro growth-inhibition test to determine susceptibility of Trypanosoma vivax stocks to various trypanocides.
Zweygarth E; Kaminsky R; Moloo SK
Onderstepoort J Vet Res; 1994 Jun; 61(2):189-91. PubMed ID: 7596569
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of an arsenical compound (RM 110, mel Cy, Cymelarsan) against susceptible and drug-resistant Trypanosoma brucei brucei and T.b. evansi.
Zweygarth E; Kaminsky R
Trop Med Parasitol; 1990 Jun; 41(2):208-12. PubMed ID: 2382101
[TBL] [Abstract][Full Text] [Related]
31. Time-dose response of Trypanosoma congolense bloodstream forms to diminazene and isometamidium.
Kaminsky R; Chuma F; Wasike RP
Vet Parasitol; 1994 Apr; 52(3-4):235-42. PubMed ID: 8073607
[TBL] [Abstract][Full Text] [Related]
32. Assessment of the occurrence of trypanocidal drug resistance in trypanosomes of naturally infected cattle in the Adamaoua region of Cameroon using the standard mouse test and molecular tools.
Mamoudou A; Delespaux V; Chepnda V; Hachimou Z; Andrikaye JP; Zoli A; Geerts S
Acta Trop; 2008 May; 106(2):115-8. PubMed ID: 18355771
[TBL] [Abstract][Full Text] [Related]
33. Occurrence of multiple drug resistance in Trypanosoma brucei rhodesiense isolated from sleeping sickness patients.
Kagira JM; Maina N
Onderstepoort J Vet Res; 2007 Mar; 74(1):17-22. PubMed ID: 17708149
[TBL] [Abstract][Full Text] [Related]
34. Reduced Mitochondrial Membrane Potential Is a Late Adaptation of Trypanosoma brucei brucei to Isometamidium Preceded by Mutations in the γ Subunit of the F1Fo-ATPase.
Eze AA; Gould MK; Munday JC; Tagoe DN; Stelmanis V; Schnaufer A; De Koning HP
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004791. PubMed ID: 27518185
[TBL] [Abstract][Full Text] [Related]
35. Variation in resistance to isometamidium chloride and diminazene aceturate by clones derived from a stock of Trypanosoma congolense.
Peregrine AS; Knowles G; Ibitayo AI; Scott JR; Moloo SK; Murphy NB
Parasitology; 1991 Feb; 102 Pt 1():93-100. PubMed ID: 2038504
[TBL] [Abstract][Full Text] [Related]
36. Sensitivity of animal-derived Trypanozoon stocks from sleeping sickness endemic foci of Nigeria to trypanocides and human plasma.
Kalu AU
Rev Elev Med Vet Pays Trop; 1995; 48(2):139-44. PubMed ID: 8552843
[TBL] [Abstract][Full Text] [Related]
37. Trypanosoma congolense: in vitro susceptibility of bloodstream forms to diminazene and isometamidium.
Kaminsky R; Chuma F; Zweygarth E
Exp Parasitol; 1993 Mar; 76(2):213-5. PubMed ID: 8454031
[No Abstract] [Full Text] [Related]
38. Occurrence of Trypanosoma spp. and piroplasm infections of horses at Obollo-Afor southeastern Nigeria and resistance profiles of trypanosomes to isometamidium and diminazene salts.
Emeto UE; Okolo CC; Nweze NE
Trop Anim Health Prod; 2020 Nov; 52(6):3745-3753. PubMed ID: 33000374
[TBL] [Abstract][Full Text] [Related]
39. The effect of trypanocidal drugs on the transmission of Trypanosoma brucei brucei by Glossina morsitans centralis.
Jefferies D; Jenni L
Acta Trop; 1987 Mar; 44(1):23-8. PubMed ID: 2884836
[TBL] [Abstract][Full Text] [Related]
40. Field studies of drug-resistant cattle trypanosomes in Kénédougou Province, Burkina Faso.
McDermott J; Woitag T; Sidibé I; Bauer B; Diarra B; Ouédraogo D; Kamuanga M; Peregrine A; Eisler M; Zessin KH; Mehlitz D; Clausen PH
Acta Trop; 2003 Apr; 86(1):93-103. PubMed ID: 12711108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
